SCIBETTA v. ACCLAIMED HEALTHCARE et al
Filing
31
MEMORANDUM AND ORDER granting in part and denying in part 23 Motion to Dismiss. Realtor will have 21 days from the entry of this Order to amend her Complaint as to Counts II and V. Signed by Judge Peter G. Sheridan on 11/22/2021. (jdb)
Case 3:16-cv-02385-PGS-DEA Document 31 Filed 11/22/21 Page 1 of 19 PageID: 372
UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF NEW JERSEY
ANNETTE SCIBETTA,
Case No.: 3:16-cv-02385 (PGS)(DEA)
Plaintiff
V.
MEMORANDUM
AND ORDER
ACCLAIMED HEALTHCARE et a!.,
Defendants.
Relator Annette Scibetta (“Relator” or “Scibetta”) brings this qui tam action on behalf of
herself, the United States, and the State of New Jersey, against Defendants AcclaiMed
Healthcare, Cane & Able, Raphael (“Ray”) Stahl, Joan Stahl, Basha Stahl, David Evan Farrer,
ABC Corporations 1-10, and Joim Does 1-10. The United States declined to intervene in the
action. (ECF No. 6). After the Court dismissed the original complaint without prejudice,
Relator filed an amended complaint. (Am. Complaint, ECF No. 20). In the present motion,
Defendants AcclaiMed Healthcare, Ray Stahl, Joan Stahl, and Basha Stahl seek dismissal of the
claims against them. (Moving Br., ECF No. 23). The Court heard oral argument on September
16, 2021. For the reasons that follow, Defendants’ motion is granted in part and denied in part.
I.
This Court has subject-matter jurisdiction over Relator’s federal claim under 28 U.S.C.
1331 and supplemental jurisdiction over her state law claims under 28 U.S.C.
§ 1367. Further,
the Court has jurisdiction over federal and state civil actions for false claims under 31 U.S.C.
3732(a) and (b). Venue is appropriate in the District of New Jersey pursuant to 31 U.S.C.
3732(a) because Defendants transact business in Lakewood, New Jersey.
§
§
§
Case 3:16-cv-02385-PGS-DEA Document 31 Filed 11/22/21 Page 2 of 19 PageID: 373
II.
Relator began working in customer service at Defendant AcclaiMed Healthcare, Inc.,
(“Defendant” or “AcclaiMed”) on January 21, 2016. (Am. Compi.
¶
12). AcclaiMed is a
healthcare organization based in Lakewood, New Jersey. (Id. at ¶ 2). Ray Stahl is the president
and/or owner of AcclaiMed, and his wife, Joan Stahl, and daughter, Basha Stahl, work for
AcclaiMed as well. (Id. at ¶J 4, 6-7). According to Relator, AcclaiMed terminated her in July
2016 “after having expressed her concern over illegal activities and advising the defendants that
she would not participate in the illegal conduct.” (Id.
¶
12).
During the course of her employment, Relator noticed sales, billing, and insurance
irregularities which led her to believe Defendant was submitting fraudulent claims for
reimbursement to state and federal health programs, including Medicaid and Medicare (“CMS”),
the United States Department of Health and Human Services, and TRICARE.’ (Id.
¶J 13-14).
Her complaint describes numerous examples of Defendants’ alleged fraud, including: (1) billing
federal and state programs for new products when used products were provided to patients; (2)
substituting inferior products for those prescribed; (3) providing fewer products than the quantity
prescribed; and (4) billing patients differently based upon their perceived religious affiliation.
(Id.
¶ 48).
A brief description of each alleged fraudulent undertaking follows:2
A) A child with the initials B.P. was routinely provided inferior diapers while TRICARE
was billed for the more expensive, prescribed diapers. (Id.
¶
16).
TRICARE is a health care program operated by the Defense Health Agency within the Department of Defense.
TRICARE. https://www.tricare.mil/About (last visited Nov. 22, 2021).
2
For the sake of simplicity, the Court will refer to those alleged undertakings by the letters assigned in the motion
to dismiss. See (Motion to Dismiss at 3-7).
2
Case 3:16-cv-02385-PGS-DEA Document 31 Filed 11/22/21 Page 3 of 19 PageID: 374
B) Patient number 14065 was routinely provided fewer cans of a nutritional supplement than
the amount prescribed; meanwhile, Medicare was billed for the prescribed amount. (Id.
¶
17-18).
C) Patient numbers 15268 and 6590 routinely received cheaper and lower-quality diapers
and pull-ups than those prescribed, while Medicare was billed for the more expensive
products. (Id.
¶
19-22; see also id.
¶ 37).
D) A patient with the initials W.B. was provided a used wheelchair while Medicare was
billed for a new wheelchair; Relator alleges this undertaking occurred with respect to
other patients as well. Further, Relator alleges Defendant(s) sought to charge W.B. a
service fee of $75 to examine the used wheelchair, exclusive of the cost of replacement
parts. (Id. ¶23).
E) AcclaiMed employees routinely clean and re-rent commodes as new when they have
been used by other patients. (Id.
¶ 24).
F) Certain customers were billed separately through Cane & Able3 at a different rate than
other AcclaiMed patients. Relator alleges these patients “have names which would give
the impression that the individuals practice the Jewish faith.” (Id.
¶ 25).
G) AcclaiMed employees, at Ray Stahl’s direction, would alter physicians’ orders regarding
the quantity, description, frequency, and length of need of prescribed products. For
example, patient number 14949 was supplied substantially more formula than that
prescribed by the doctor, and various details were changed regarding patient number
1745’s prescribed order. (Id.
¶ 26).
Relator alleges that Cane & Able, Inc. is a seller of Medicare chargeable items based in Langhorne, Pennsylvania.
(Id. ¶ 3). Cane & Enable is listed as a division of Cane & Able, and Relator refers to both companies collectively as
“Cane & Able.” (Id. ¶ 5).
3
Case 3:16-cv-02385-PGS-DEA Document 31 Filed 11/22/21 Page 4 of 19 PageID: 375
H) Joan Stahl fraudulently represented herself as a respiratory therapist when she attended to
patient number 1745 in a hospital to adjust oxygen levels. Further, on April 6, 2016, a
doctor called asking to speak to the respiratory therapist and was redirected to Joan Stahl.
On information and belief Relator alleges that this visit was billed to Medicare. (Id.
¶
27).
I) Defendants frequently continued billing Medicare and other state and federal providers
for products after they were returned by patients. For example, patient number 20098
died and the medical equipment provided was returned, but AcclaiMed kept billing
Medicare for the equipment as if the patient was alive. Similar allegations concern D.H.,
W.M., L.J., C.C., M.P., S.K., J.M.V., and patient number 17717. (Id.
¶J 29-33,
36). In
addition, patient number 20105 and a patient with the initials J.B. never received products
that were billed to Medicare. (Id.
¶J 34, 45).
J) Ray Stahl added products to the delivery ticket, changed the prescription, and billed
Medicare for a patient with the initials E.R. He also asked Relator to change the CMN
(certificate of medical necessity) for that patient, but Relator refused to do so. (Id.
¶ 35).
K) Defendants continued billing Medicare for a commode after the patient returned the
product. In addition, Ray Stahl directly charged the patient for an upgrade, which Relator
believes is impermissible under CMS rules and regulations. (Id.
¶ 38).
L) Defendants billed CMS for more than twice the actual cost of an ear sensor for patient
number 15151. Realtor believes this violates CMS’s requirement that products be billed
at the “best price.” (Id.
¶ 39).
M) Patient R.K. was either supplied less of the prescribed product or a lower quality product.
(Id. ¶40).
4
Case 3:16-cv-02385-PGS-DEA Document 31 Filed 11/22/21 Page 5 of 19 PageID: 376
N) Defendants double billed for patient number 19442’s catheters
—
specifically, Defendants
collected $76.80 from the patient out of pocket and billed Medicare for the same amount.
(Id.
¶ 41). Relator alleges a similar undertaking with respect to patient number
(Id.
¶ 46).
19452.
0) Medicare was billed for more catheters than the number delivered to patient number
18820. (Id. ¶42).
P) Patient number 12036’s monthly orders were “downgraded.” Although unclearly stated,
Relator alleges that Medicare was billed excessively because the value of the products
was overvalued. (Id.
¶ 43).
Q) A pulse oximeter was ordered for patient T.B. and the coding was changed either from a
purchase to a rental or vice versa. (Id.
¶ 44).
Based on the above allegations, Relator asserts the following violations in her six-count
complaint: (1) Federal False Claims Act (Count I); (2) Conspiracy to violate the Federal False
Claims Act (Count II); (3) New Jersey False Claims Act (Count III); (4) Conspiracy to violate
the New Jersey False Claims Act (Count IV); (5) New Jersey RICO (Count V); and (6)
Retaliation (Count VI).
III.
Federal Rule of Civil Procedure 12(b)(6) provides that an action may be dismissed for
“failure to state a claim upon which relief can be granted.” “In deciding a Rule 12(b)(6) motion,
a court must take all allegations in the complaint as true and view them in the light most
favorable to the plaintiff.” United States v. Loving Care Agency, Inc., 226 F. Supp. 3d 357, 36263 (D.N.J. 2016). The plaintiff’s factual allegations must give rise to a claim for relief that is
“plausible on its face.” Bell Atl. Corp. v. Twombly, 550 U.S. 544, 570 (2007). A claim has
5
Case 3:16-cv-02385-PGS-DEA Document 31 Filed 11/22/21 Page 6 of 19 PageID: 377
“facial plausibility when the plaintiff pleads factual content that allows the court to draw the
reasonable inference that the defendant is liable for the misconduct alleged.” Ashcroft v. Iqbal,
556 U.s. 662, 678 (2009). The question is whether the claimant can prove any set of facts
consistent with his or her allegations that will entitle him or her to relief, not whether that person
will ultimately prevail. Semerenko v. Cendant Corp., 223 F.3d 165, 173 (3d Cir. 2000), cert.
denied, 531 U.s. 1149 (2001).
The Third Circuit set forth a three-part test for determining whether not a complaint may
survive a motion to dismiss for failure to state a claim:
First, the court must “tak[ej note of the elements a plaintiff must
plead to state a claim.” Second, the court should identify allegations
that, “because they are no more than conclusions, are not entitled to
the assumption of truth.” Finally, “where there are well-pleaded
factual allegations, a court should assume their veracity and then
determine whether they plausibly give rise to an entitlement for
relief.”
Santiago v. Warminster Township, 629 F.3d 121, 130 (3d. Cir. 2010) (alteration in original)
(quoting Iqbal, 556 U.S. at 675, 679).
When a complaint involves allegations of fraud, a plaintiff must meet the heightened
pleading requirements of Fed. R. Civ. P. 9(b) to state a claim that survives under a Fed. R. Civ.
P. 12(b)(6) challenge. Foglia v. Renal Ventures Mgmt., LLC, 754 F.3d 153, 155 (3d Cir. 2014).
Under Rule 9(b), “a party must state with particularity the circumstances constituting fraud or
mistake.” The purpose of Rule 9(b) is to “provide[ I defendants with fair notice of the plaintiffs’
claims.” Foglia, 754 F.3d at 156.
Regarding Rule 9(b)’s particularity requirement, the Third Circuit has held that a plaintiff
need only allege “particular details of a scheme to submit false claims paired with reliable indicia
that lead to a strong inference that claims were actually submitted.” Id. at 155-5 8. A plaintiff
6
Case 3:16-cv-02385-PGS-DEA Document 31 Filed 11/22/21 Page 7 of 19 PageID: 378
need not “identify a specific claim for payment at the pleading stage of the case to state a claim
for relief.” Id. at 156. “Courts.
.
.
have found that a plaintiff may satisfy that requirement in one
of two ways: (1) ‘by pleading the date, place, or time of the fraud’; or (2) using an ‘alternative
means of injecting precision and some measure of substantiation into their allegations of fraud.”
Loving, 226 F. Supp. 3d at 363 (quoting Flanagan v. Bahal, No. 12—cv—2216, 2015 WL
9450826, at *3 (D.N.J. Dec. 22, 2015)).
Iv.
A. False Claims Act
i.
Federal Law
Relator does not plead a violation of a specific provision of the Federal False Claims Act
but, based on the language in Count I and the facts presented in the complaint, the Court
surmises she is alleging violations of subsections (a)(1)(A) and (a)(1)(B). Those provisions state
that a person is liable under the False Claims Act who “knowingly presents, or causes to be
presented, a false or fraudulent claim for payment or approval,” or “knowingly makes, uses, or
causes to be made or used, a false record or statement material to a false or fraudulent claim.” 31
U.S.C.
§ 3729(a)(1)(A) and (B).4
The False Claims Act defines several key terms used in the above sections. First, a
“claim” is
“There are two categories of false claims under the FCA: a factually false claim and a legally false claim. A claim
is factually false when the claimant misrepresents what goods or services that it provided to the Government and a
claim is legally false when the claimant knowingly falsely certifies that it has complied with a statute or regulation
the compliance with which is a condition for Government payment. Legally false claims may be express or implied.
For legally false claims, plaintiffs must plead that the regulation at issue is material.” United States v. Andover
Subacute & Rehab Ctr. Servs. One, Inc., No. CV 12-03319-SDW-SCM, 2019 WL 4686963, at *4 (D.N.J. Sept. 26,
2019) (citations omitted) (quoting US. ex rel. Wilkins v. United Health Grp., Inc., 659 F.3d 295 (3d Cir. 2011)).
The parties disagree as to whether Relator relies on a factually false or legally false claim theory, or both. (See
Moving Br. at 9; Opp. Br. at 6-9). Relator does not explicitly assert a particular theory in her Amended Complaint,
though she alleges that Defendants both submitted false claims and falsely certified their compliance with CMS
regulations. (See, e.g., Am. Compl. ¶ 15, 23, 26, 53).
‘
7
Case 3:16-cv-02385-PGS-DEA Document 31 Filed 11/22/21 Page 8 of 19 PageID: 379
any request or demand, whether under a contract or otherwise, for
money or property and whether or not the United States has title to
the money or property, that(i) is presented to an officer, employee, or agent of the
United States; or
(ii) is made to a contractor, grantee, or other recipient, if the
money or property is to be spent or used on the Government’s
behalf or to advance a Government program or interest, and
if the United States Government(I) provides or has provided any portion of the money
or property requested or demanded; or
(II) will reimburse such contractor, grantee, or other
recipient for any portion of the money or property
which is requested or demanded.
31 U.S.C.
§ 3729(b)(2)(A).
Second, the term “knowingly” means that a defendant “(i) has actual knowledge of the
information; (ii) acts in deliberate ignorance of the truth or falsity of the information; or (iii) acts
in reckless disregard of the truth or falsity of the information.” 31 U.S.C.
§ 3729(b)(l)(A). As
an example, the Supreme Court stated:
If the Government failed to specify that guns it orders must actually
shoot, but the defendant knows that the Government routinely
rescinds contracts if the guns do not shoot, the defendant has “actual
knowledge.” Likewise, because a reasonable person would realize
the imperative of a functioning firearm, a defendant’s failure to
appreciate the materiality of that condition would amount to
“deliberate ignorance” or “reckless disregard” of the “truth or falsity
of the information” even if the Government did not spell this out.
Universal Health Servs., Inc. v. United States ex rel. Escobar, 136 5. Ct. 1989, 2001-02 (2016).
No proof of specific intent to defraud is required to plead that a person acted “knowingly.” 31
U.S.C.
§ 3729(b)(l)(B).
Third, “the term ‘material’ means having a natural tendency to influence, or be capable of
influencing, the payment or receipt of money or property.” 31 U.S.C.
§ 3729(b)(4). In Escobar,
the Supreme Court described this standard as “demanding,” citing cases in which it was clear
8
Case 3:16-cv-02385-PGS-DEA Document 31 Filed 11/22/21 Page 9 of 19 PageID: 380
that a party would not have paid funds or signed a contract if it knew about the misrepresentation
in question. See 136 S. Ct. at 2003. See also United States ex rel. Doe v. Heart Sol., Pc, 923
F.3d 308, 3 17-18 (3d Cir. 2019).
At least several of Relator’s factual allegations are sufficient to state a claim for relief
under the False Claims Act. For example, some of the alleged undertakings entail billing federal
health care programs for more or higher-quality products than those delivered to patients. (See,
e.g., Undertakings A-D, M, 0). Others involve double billing for the same product. (See
Undertaking N). And in others, Defendants continued billing CMS for equipment that had been
returned by patients, or after patients were deceased. (See Undertakings I, K; Am. Compl. Exs.
G, T, U). In each of these scenarios, Defendants’ claims for reimbursement allegedly contained
false or misleading information about how much money the government owed AcclaiMed.
Under the statutory definition of “knowingly” and the Supreme Court’s interpretation of
that term, Relator has sufficiently alleged that Defendants either (1) had actual knowledge of
their misrepresentations to the government, or (2) were deliberately ignorant of— or recklessly
disregarded
§
—
the truth or falsity of the information they provided to the government. 31 U.S.C.
3729(b)(1)(A); Escobar, 136 5. Ct. at 200 1-02. The facts asserted in the Amended Complaint
suggest that Defendants’ acts were deliberate, such as Relator’s allegations that Defendants
engaged in fraudulent billing practices or instructed her to do so
expressed discomfort. (See, e.g., Am. Compi.
¶
—
even when she refused or
15-16, 26, 35, 41).
Likewise, Relator has adequately alleged that Defendants’ misrepresentations were
“material to a false or fraudulent claim” because they had “a natural tendency to influence, or
[were] capable of influencing, the payment or receipt of money or property.” 31 U.S.C.
3729(a)(1)(B); 31 U.S.C.
§
§
3729(b)(4). The government would undoubtedly refuse to reimburse
9
Case 3:16-cv-02385-PGS-DEA Document 31 Filed 11/22/21 Page 10 of 19 PageID: 381
AcclaiMed if it knew that patients received fewer or inferior products than what was billed, that
patients had already paid AcclaiMed out-of-pocket for certain claims, or that AcclaiMed was
billing for equipment that was no longer in use by patients. See Escobar, 136 S. Ct. at 2003.
Overall, Relator has met her burden to state a claim under the heightened pleading
requirements of Fed. R. Civ. P. 9(b) and related case law in this District. See Loving, 226 F.
Supp. 3d at 363, 366. She has pleaded specific facts
—
with supporting documentation
—
about
the patients for whom she alleges fraudulent claims were submitted. These documents identify
particular patients, transactions, prescriptions, delivery information, and other details that
“inject[] precision and some measure of substantiation into [Relator’s] allegations of fraud.”
Loving, 226 F. Supp. 3d at 363. She also attaches notes and correspondence with third parties
that lend support to her allegations, and at least one copy of a bill that was submitted to
Medicare. (See Am. Compl. Exs. F-J, L, S). Taken together, Relator has sufficiently alleged
“particular details of a scheme to submit false claims paired with reliable indicia that lead to a
strong inference that claims were actually submitted.” Foglia, 754 F.3d at 155-5 8. As such, the
Court will deny Defendants’ motion to dismiss Count I of the Amended Complaint.
ii.
State Law
The New Jersey False Claims Act contains similar prohibitions as its federal counterpart.
In relevant part, it imposes liability on a person who “[k]nowingly presents or causes to be
presented to an employee, officer or agent of the State, or to any contractor, grantee, or other
recipient of State funds, a false or fraudulent claim for payment or approval;” or “[k]nowingly
makes, uses, or causes to be made or used a false record or statement to get a false or fraudulent
claim paid or approved by the State.” N.J. Stat. Ann.
§ 2A:32C-3(a), (b). One notable
difference between the State and Federal statutes is that the New Jersey law does not contain a
10
Case 3:16-cv-02385-PGS-DEA Document 31 Filed 11/22/21 Page 11 of 19 PageID: 382
materiality requirement. The New Jersey False Claims act defines the terms “claim” and
“knowingly” in substantially the same manner as its federal counterpart. Compare N.J. Stat.
Ann.
§ 2A:32C-2 with 31 U.S.C. § 3729(b)(1), (b)(2)(A).
Because the New Jersey False Claims Act essentially mirrors the Federal False Claims
Act with respect to the applicable sections in the instant case, the Court’s analysis is the same
under both statutes. See Loving, 226 F. Supp. 3d at 363-64. For the same reasons articulated in
Section A.i, the Court finds Relator has sufficiently stated a claim under the New Jersey False
Claims Act and denies Defendants’ motion to dismiss Count III of the Amended Complaint.
B. Conspiracy
i.
Federal Law
Under the Federal False Claims Act, conspiracy to violate the Act is a violation of the
Act itself. 31 U.S.C.
§ 3729(a)(1)(C). In Count II of the Amended Complaint, Relator alleges
Defendants “conspired with each other to defraud the United States when they ‘knowingly made,
used or caused to be made or used, a false record or statement to conceal, avoid, or decrease an
obligation to pay or transmit money or property to the Government.” (Am. Compi. Count II
2). That allegation invokes the language in 31 U.S.C.
¶
§ 3729(a)(1)(G), which is known as the
“reverse false claims” provision of the False Claims Act.5 See Alice G. Gosfield, Medicare and
Medicaid Fraud and Abuse
§ 5:10 (2020). However, Relator has not asserted a violation of that
provision.
The facts alleged in Relator’s complaint center around Defendants’ submission of
fraudulent claims
—
or statements material to fraudulent claims
—
under 31 U.S.C.
§
The reverse false claims provision imposes liability on a person who “knowingly makes, uses, or causes to be
made or used, a false record or statement material to an obligation to pay or transmit money or property to the
Government, or knowingly conceals or knowingly and improperly avoids or decreases an obligation to pay or
transmit money or property to the Government.” 31 U.S.C. § 3729(a)(1)(G).
11
Case 3:16-cv-02385-PGS-DEA Document 31 Filed 11/22/21 Page 12 of 19 PageID: 383
3729(a)(1)(A) and (a)(l)(B). Essentially, she alleges that Defendants over-billed government
health care programs in their claims for reimbursement, which caused (or was capable of
causing) the government to over-pay Defendants. (Am. Compi. Count II ¶ 7). By contrast, a
reverse false claim means that a defendant improperly avoided or reduced its own financial
obligation to the government. Relator has not pleaded facts that show Defendants had an
“obligation to pay or transmit money or property to the Government,” or that they conspired to
conceal, avoid, or decrease that obligation. See 31 U.S.C.
§
3729(a)(1)(G).
Overall, Relator has not stated a claim for conspiracy to violate 31 U.S.C.
§
3 729(a)(1)(G). As a result, the Court will dismiss Count II of the Amended Complaint without
prejudice. This Court will provide Relator an opportunity to amend her complaint.
ii.
State Law
A person violates the New Jersey False Claims Act if s/he “[c]onspires to defraud the
State by getting a false or fraudulent claim allowed or paid by the State.” N.J. Stat. Ann.
§
2A:32C-3(c). In Count IV of the Amended Complaint, Relator alleges Defendants “conspired
with each other to defraud the State of New Jersey specifically, for monies that were paid by the
State of New Jersey for services or products by AcclaiMed Healthcare and/or Cane & Able.”
(Am. Compi. Count IV
¶ 2).
Relator alleges AcclaiMed, Cane & Able, and/or the individual
defendants shared patients and billing information “to effectuate the false or fraudulent claims
for payment,” and cites a news article6 in which David Farrer, President of Cane & Able,
referenced its partnership with AcclaiMed. (Am. Compi. Count IV ¶ 3-4; see also Am. Compi.
¶5,49).
6
Crissa Shoemaker DeBree, Cane & Able reopens for business in Penndel, Bucks Cty. Courier Times (Aug. 29,
2014, 12:01 AM), https://www.buckscountycouriertimes.com/article/20 140829/BUSINESS/308299843.
12
Case 3:16-cv-02385-PGS-DEA Document 31 Filed 11/22/21 Page 13 of 19 PageID: 384
“In order to state a conspiracy claim under the [Federal False Claims Act], a plaintiff
must allege ‘(1) a conspiracy to get a false or fraudulent claim allowed or paid; and (2) an act in
furtherance of the conspiracy.” United States v. Medco Health Sys., Inc., No. CIV. 12-522
(NLH), 2014 WL 4798637, at * 11 (D.N.J. Sept. 26, 2014) (quoting US. ex rel. Lampkin v.
Johnson & Johnson, Inc., No. CIV.A. 08-05362 (JAP), 2013 WL 2404238, at *5 (D.N.J. May
31, 2013)). “Critically, ‘{t]he essence of a conspiracy under the Act is an agreement between
two or more persons to commit fraud.” Id. (alteration in original). While the elements of a
conspiracy claim under the New Jersey False Claims Act are not specifically set forth in the case
law, a “civil conspiracy” is defined as
a combination of two or more persons acting in concert to commit
an unlawful act, or to commit a lawful act by unlawful means, the
principal element of which is an agreement between the parties to
inflict a wrong against or injury upon another, and an overt act that
results in damage.
Banco Popular N Am. v. Gandi, 876 A.2d 253, 263 (N.J. 2005) (quoting Morgan v. Union Cty.
Bd. of Chosen Freeholders, 633 A.2d 985, 998 (N.J. Super. Ct. App. Div. 1993)).
Both federal and state definitions above require an agreement between two or more
persons, plus an act in furtherance of the conspiracy. Here, there are insufficient facts in the
Amended Complaint to satisfy those criteria. Relator simply makes general allegations about a
“relationship” between AcclaiMed and Cane & Able, and she does not plead any facts that show
there was an agreement between any two defendants to submit false claims. (See Am. Compi.
Count IV ¶ 4). Merely alleging that two companies shared patients and billing information to
effectuate the submission of false claims is insufficient to state a claim for conspiracy. (See Am.
Compl. Count IV
¶ 3).
13
Case 3:16-cv-02385-PGS-DEA Document 31 Filed 11/22/21 Page 14 of 19 PageID: 385
Further, to the extent Relator alleges the purported conspiracy involved charging patients
different rates based on their perceived religion, she has not pleaded enough facts to support her
claim. (See Am. Compi.
¶ 25). Even if her allegation were correct, it is not clear how charging
some patients less than others plausibly led to the submission of false claims to the government.
For the foregoing reasons, Relator has failed to state a claim for conspiracy to violate the
New Jersey False Claims Act, and the Court will grant Defendants’ motion to dismiss Count IV
of the Amended Complaint.
C. New Jersey RICO
New Jersey’s RICO statute permits “[a]ny person damaged in his business or property by
reason of a violation of N.J.S. 2C:41-2” to sue and recover damages. N.J. Stat. Ann.
§ 2C:41-4.
Relator contends Defendants engaged in a pattern of racketeering activity, in violation of N.J.
Stat. Ann.
§ 2C:41-2, which caused damage to her “business or property” in the form of her lost
employment and diminished reputation. (Am. Compi. Count V ¶ 16-22). However, her
complaint does not plead any details about her injury, or how that injury was caused by
Defendants’ alleged racketeering conduct. The Court cannot infer specific damage to her
“business or property” based on this vague, unsupported, and conclusory allegation.
Further, while the government may have been injured by Defendants’ conduct, New
Jersey RICO does not contain a qui tam provision that allows private persons to sue on the
government’s behalf. Rather, an individual must have standing in the form of an injury
“proximately caused by the RICO predicate acts” to bring an action under this statute,
Interchange State Bank v. Veglia, 668 A.2d 465, 472 (N.J. Super. Ct. App. Div. 1995); see also
Fairfax Fin. Holdings Ltd. v. S.A.C. Capital Mgmt., L.L.C., 160 A.3d 44, 66 (N.J. Super. Ct.
App. Div. 2017), and Relator has not pleaded sufficient facts regarding her alleged injury. As
14
Case 3:16-cv-02385-PGS-DEA Document 31 Filed 11/22/21 Page 15 of 19 PageID: 386
such, Relator has failed to state a claim under New Jersey RICO, and Count V of the Amended
Complaint will be dismissed. The Complaint will be dismissed without prejudice to allow
Relator an opportunity to plead details of her alleged injury.
D. Retaliation
Count VI of the Amended Complaint alleges Defendants retaliated against Relator by
harassing, threatening, and ultimately firing her. (Am. Compi. Count VI ¶ 3-4).
The federal False Claims Act protects whistleblowers from retaliatory actions by
employers as follows:
Any employee, contractor, or agent shall be entitled to all relief
necessary to make that employee, contractor, or agent whole, if that
employee, contractor, or agent is discharged, demoted, suspended,
threatened, harassed, or in any other manner discriminated against
in the terms and conditions of employment because of lawful acts
done by the employee, contractor, agent or associated others in
furtherance of an action under this section or other efforts to stop 1
or more violations of this subchapter because of lawful acts done by
the employee, contractor, agent or associated others in furtherance
of an action under this section or other efforts to stop 1 or more
violations of this subchapter.
31 U.S.C.
§
3730(h).
To state a prima facie case of retaliation under
§
3 730(h), “a plaintiff must show his
employer had knowledge that he was engaged in ‘protected conduct’ and that the employer
retaliated against him because of that conduct.” Hutchins v. Wilentz, Goldman & Spitzer, 253
F.3d 176, 188 (3d Cir. 2001). See also United States ex rel. Petras v. Simparel, Inc., 857 F.3d
497, 507 (3d Cir. 2017). There must be a “nexus” between the protected activity and the
retaliation. Hutchins, 253 F.3d at 188. “An employer’s notice of the ‘distinct possibility’ of
False Claims Act litigation is essential because without knowledge an employee is contemplating
a False Claims Act suit, ‘there would be no basis to conclude that the employer harbored
15
[
Case 3:16-cv-02385-PGS-DEA Document 31 Filed 11/22/21 Page 16 of 19 PageID: 387
3730(h)’s] prohibited motivation [i.e., retaliation].” Id. (alterations in original) (quoting Mann
v. Olsten CertfiedHealthcare Corp., 49 F. Supp. 2d 1307, 1314 (M.D. Ala. 1999)). “[T]he
employer is on notice of the ‘distinct possibility’ of litigation when an employee takes actions
revealing the intent to report or assist the government in the investigation of a False Claims Act
violation.” Id. at 189.
Whether an action constitutes protected conduct is an “intensely factual” question. Id.
Protected conduct may include “investigation for, initiating of, testimony for, or assistance in a
[FCA] suit,” id. at 187, or reporting “fraudulent and illegal activity” to an employer, id. at 189.
However, protected conduct does not include “an employee’s investigation of nothing more than
his employer’s non-compliance with federal or state regulations.” Id. at 187-88.
Under the New Jersey False Claims Act,
No employer shall discharge, demote, suspend, threaten, harass,
deny promotion to, or in any other manner discriminate against an
employee in the terms and conditions of employment because of
lawful acts done by the employee on behalf of the employee or
others in disclosing information to a State or law enforcement
agency or in furthering a false claims action, including investigation
for, initiation of testimony for, or assistance in an action filed or to
be filed under this act.
N.J. Stat. Ann.
§ 2A:32C-10.
Here, Relator has not sufficiently pled her retaliation claims. She alleges she engaged in
protected conduct, specifically that she made “direct, vocal and constant complaints related to
the various defendants[’] violations of the law.” (Am. Compl. Count VI ¶ 3-4). These
allegations are too vague. This Court cannot discern from the Amended Complaint: which
individual or individuals Relator complained to and whether they were in such a position to place
16
Case 3:16-cv-02385-PGS-DEA Document 31 Filed 11/22/21 Page 17 of 19 PageID: 388
the defendants on notice of her possible FCA claim7; whether Relator specifically informed
defendants she planned to file an FCA claim; or whether Relator specified in her complaints that
she believed defendants were violating the law, see Petre v. Alliance Healthcare Mgmt., LLC,
No. 20-9002, 2021 WL 1085522 (D.N.J. Mar. 22, 2021); Un ited States v. Pioneer Educ., LLC,
No. 16-18 17, 2020 WL 4382275 at *5 (D.N.J. Jul. 31, 2020). In sum, it is unclear if Relator’s
complaints actually placed Defendants on notice of a potential FCA claim. 8 Hutchins, 253 F.3d
at 188.
Second, she states that she “was continually harassed and/or threatened by her employer
because of [her] willful expressions or acts.
.
.
in furtherance of the action,” and “was terminated
due to her direct, vocal and constant complaints related to the various defendants violations of
the law.” (Am. Compi. Count VI
¶ 3-4).
While termination is certainly a form of FCA
retaliation, Hutchins, 253 F.3d 195, the complaint is devoid of any facts which could indicate a
nexus between her protected acts and retaliation by defendants, id. at 188, aside from conclusory
allegations of such a nexus.
For the foregoing reasons, Relator has failed to state a claim for retaliation under the
Federal or New Jersey False Claims Acts. Relator’s complaint also attempts to assert a
retaliation claim under “other statutes, rules, codes or other protections” in addition to the state
and federal False Claims Acts; however, the Court declines to infer violations of laws or
regulations not specifically pleaded. In sum, Count VI of the Amended Complaint is dismissed
with prejudice.
For example, the knowledge of officers, directors, or “key employees” may be imputed to the corporation.
Gerling int’l ins. Co. v. Comm ‘r Gerling int’l Ins. Co., 839 F.2d 131, 138-39 (3d Cir. 1988)
8
Any actions putting Defendant on notice would have taken place before Relator filed the present action. Thus,
Relator’s argument that she was prohibited from discussing her False Claims Act complaint after it was filed under
seal is not compelling. (See Opp. Br. 20, ECF No. 24).
17
Case 3:16-cv-02385-PGS-DEA Document 31 Filed 11/22/21 Page 18 of 19 PageID: 389
CONCLUSION
Because Relator has stated a claim for relief under the Federal and New Jersey False
Claims Acts, Defendants’ motion to dismiss is denied with respect to Counts I and III of the
Amended Complaint. Defendants’ motion to dismiss is granted as to the other counts of the
complaint because Relator has failed to state a claim for retaliation (Count VI), a violation of
New Jersey’s RICO law (Count V), and conspiracy to violate the Federal and New Jersey False
Claims Acts (Counts II and IV).
18
Case 3:16-cv-02385-PGS-DEA Document 31 Filed 11/22/21 Page 19 of 19 PageID: 390
ORDER
THIS MATTER having come before the Court on Defendant’s Motion to Dismiss
Relator’s Amended Complaint (ECF No. 23); and the Court having carefully reviewed and taken
into consideration the submissions of the parties, as well as the arguments and exhibits therein
presented; and for good cause shown; and for all of the foregoing reasons,
IT IS on this ?>day
ORDERED that Defendant’s motion to dismiss (ECF No. 23) is granted in part and
denied in part, as follows:
(1) Defendant’s motion is denied as to Counts I and III; and
(2) Defendant’s motion is granted as to Counts II, IV, V, and VI. Counts II and V will be
dismissed without prejudice. Counts IV and VI will be dismissed with prejudice.
(3) Relator will have 21 days from the entry of this order to amend her complaint as to
Counts II and V.
I
j
41
1
J v1k.
PETER G. SHERIDAN, U.S.D.J.
19
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?